Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer

Young Saing Kim,Eun Kyung Cho,Hyun Sun Woo,Junshik Hong,Hee Kyung Ahn,Inkeun Park,Sun Jin Sym,Sun Young Kyung,Shin Myung Kang,Jeong-Woong Park,Sung Hwan Jeong,Jinny Park,Jae Hoon Lee,Dong Bok Shin

Randomized Phase II Study of Pemetrexed Versus Gefitinib in Previously Treated Patients with Advanced Non-small Cell Lung Cancer

2015

Young Saing Kim
Eun Kyung Cho
Hyun Sun Woo
Junshik Hong
Hee Kyung Ahn
Inkeun Park
Sun Jin Sym
Sun Young Kyung
Shin Myung Kang
Jeong-Woong Park
Sung Hwan Jeong
Jinny Park
Jae Hoon Lee
Dong Bok Shin

Purpose This study aimed to evaluate the efficacy and safety of pemetrexed versus gefitinib in patients with advanced non-small cell lung cancer (NSCLC) previously treated with chemotherapy.

Keywords:

Pemetrexed
Phases of clinical research
Epidermal growth factor receptor
Gefitinib
General surgery
Lung cancer
Medicine
Chemotherapy
Rash
Internal medicine
Tolerability
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations